{
    "id": 19876,
    "fullName": "BCL2 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "BCL2 dec exp indicates decreased expression of the Bcl2 protein. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 596,
        "geneSymbol": "BCL2",
        "terms": [
            "BCL2",
            "Bcl-2",
            "PPP1R50"
        ]
    },
    "variant": "dec exp",
    "createDate": "03/18/2016",
    "updateDate": "05/15/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5220,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, decreased Bcl2 expression through Bcl2-siRNA silencing potentiated the anti-tumor effect of Taxol (paclitaxel) in cell line xenograft models of glioblastoma (PMID: 19473291).",
            "molecularProfile": {
                "id": 20309,
                "profileName": "BCL2 dec exp"
            },
            "therapy": {
                "id": 1103,
                "therapyName": "Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4927,
                    "pubMedId": 19473291,
                    "title": "Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19473291"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20309,
            "profileName": "BCL2 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}